MedPath

Effect of Amritadhi Kwath In Gout

Phase 3
Not yet recruiting
Conditions
Other deformities of toe(s) (acquired). Ayurveda Condition: VATARAKTAM,
Registration Number
CTRI/2022/07/044300
Lead Sponsor
Madan mohan Malviya Government Ayurved College
Brief Summary

This is a clinical study to evaluate the therapeutic effect  of Amritadhi kwath in vatarakta .it is a single arm study in which 30 patients will be administered with 40 ml of amritadhi kwath bd.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria
  • 1.The Patients having clinical sign & symptoms of vatarakta /gout.
  • 2.Gout patients with uric acid level more than this normal range.(normal range 2.0 -8.5 mg/dl).
Exclusion Criteria
  • who are suffering from uncontrolled diabetes ,joints pathologies other than arthritis .
  • 2.Other disease such as Paralysis,parkinsons disease & cancer patients.
  • 3.The patients having complain more than 3 year duration.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Improvement in sign & symptoms of vatarakta.2 weeks
2.Improvement in Uric acid level2 weeks
Secondary Outcome Measures
NameTimeMethod
1. Improvement in sign & symptoms of vatarakta.2.Improvement in Uric acid level

Trial Locations

Locations (1)

Madan Mohan Malviya Government Ayurved College

🇮🇳

Udaipur, RAJASTHAN, India

Madan Mohan Malviya Government Ayurved College
🇮🇳Udaipur, RAJASTHAN, India
Dr Hemlata Meena
Principal investigator
8003049615
hemlatameena321@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.